VYGR Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $2.45

Capitalizzazione di Mercato (MRQ) $150M

P/E (TTM) -1.4

EPS (TTM) $-1.81

Ricavi (TTM) $34M

ROE (TTM) -54.1%

Intervallo 52 sett. $2–$6

VYGR Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Voyager Therapeutics, Inc. - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaBiotechnology dipendenti141 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$40M

2016-12-31 → 2025-12-31

EPS$-2.04

2018-12-31 → 2025-12-31

Flusso di cassa libero$-135M

2016-12-31 → 2025-12-31

Margine netto-312.6%

2016-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	VYGR	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-1.4media 5 anni ≈-2.1	≈-2.1	·	·
P/S (TTM)	4.4media 5 anni ≈3.9	≈3.9	6.4	Valore equo
P/B (MRQ)	1.0media 5 anni ≈1.8	≈1.8	2.6	Sottovalutato
Prezzo / FCF (TTM)	-1.2media 5 anni ≈-6.2	≈-6.2	·	·
Prezzo / Flusso di cassa (TTM)	-1.2media 5 anni ≈-7.6	≈-7.6	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	0.7media 5 anni ≈1.8	≈1.8	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	VYGR	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-340.1%media 5 anni ≈-140.6%	≈-140.6%	-314.1%	Debole
EBITDA Margin (Margine EBITDA)	-326.6%media 5 anni ≈-140.6%	≈-140.6%	-215.3%	Debole
Margine ante imposte (TTM)	-312.3%media 5 anni ≈-109.1%	≈-109.1%	-772.6%	In linea
Margine di Profitto Netto (TTM)	-312.6%media 5 anni ≈-125.7%	≈-125.7%	-536.3%	Sotto la media
ROA (TTM)	-41.4%media 5 anni ≈-12.1%	≈-12.1%	-55.2%	Di prim'ordine
ROE (TTM)	-54.1%media 5 anni ≈-31.2%	≈-31.2%	-60.0%	In linea
ROIC	-67.3%media 5 anni ≈-32.6%	≈-32.6%	-60.0%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	VYGR	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		7.5media 5 anni ≈4.5	≈4.5	8.1	Bassa liquidità
Quick Ratio (MRQ)		7.1media 5 anni ≈4.4	≈4.4	7.8	Bassa liquidità

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	VYGR	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	-49.5%media 5 anni ≈65.0%	≈65.0%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	-0.44%media 5 anni ≈14.0%	≈14.0%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	-25.1%	·	·	·
EPS CAGR 3Y (CAGR EPS 3 anni)	44.7%	·	·	·
Net Income CAGR 3Y (CAGR Utile Netto 3 anni)	53.3%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	VYGR	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-2.04media 5 anni ≈$-0.66	≈$-0.66	·	·
Revenue / Share (Ricavi / Azione)	$0.69media 5 anni ≈$1.95	≈$1.95	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-2.26media 5 anni ≈$-0.50	≈$-0.50	·	·
Cash / Share (Liquidità / Azione)	$1.11media 5 anni ≈$1.93	≈$1.93	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	VYGR	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.1media 5 anni ≈0.3	≈0.3	0.1	Di prim'ordine
Receivables Turnover (Rotazione dei crediti)	24.7media 5 anni ≈11.0	≈11.0	14.1	Di prim'ordine
Revenue / Employee (Ricavi / Dipendente)	≈$286.3K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 6.1%

Prossimo report Nov 08, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 4, 2026	$-0.40	$-0.49	19.0%
31 Marzo 2026	Mag 12, 2026	$-0.47	$-0.56	16.4%
31 Dicembre 2025		$-0.46	$-0.52	11.7%
30 Settembre 2025		$-0.47	$-0.53	11.5%
30 Giugno 2025		$-0.57	$-0.54	-6.3%
31 Marzo 2025		$-0.53	$-0.46	-15.7%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 14

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	$40M	$80M	$250M	$41M	$37M	$171M	$104M	$8M	$10M	$14M	$17M
R&D Expense	$135M	$127M	$92M	$61M	$74M	$109M	$120M	$65M	$62M	$42M	$28M
SG&A Expense	$38M	$36M	$36M	$31M	$37M	$35M	$36M	$34M	$20M	$13M	$10M
Operating Expenses	$172M	$163M	$128M	$92M	$111M	$144M	$156M	$99M	$82M	$56M	$38M
Operating Income	$-132M	$-83M	$122M	$-51M	$-74M	$27M	$-52M	$-91M	$-72M	$-41M	$-20M
Other Non-op	$2M	$622.0K	$3.0K	$3M	$3M	$8M	$2M	$-683.0K	$-62.0K	$182.0K	$-10M
Pretax Income	$-120M	$-64M	$134M	$-46M	$-71M	$37M	$-44M	$-88M	$-71M	$-40M	$-30M
Income Tax	$144.0K	$665.0K	$1M	$16.0K	·	·	·	$-180.0K	·	$52.0K	$0
Net Income	$-120M	$-65M	$132M	$-46M	$-71M	$37M	$-44M	$-88M	$-71M	$-40M	$-30M
EPS (Basic)	$-2.04	$-1.13	$3.08	$-1.21	$-1.89	$0.99	$-1.21	$-2.75	·	·	·
EPS (Diluted)	$-2.04	$-1.13	$2.97	$-1.21	$-1.89	$0.98	$-1.21	$-2.75	·	·	·
Shares (Basic)	58,691,136	57,667,543	43,020,747	38,356,810	37,668,947	37,132,447	35,898,266	32,065,781	·	·	·
Shares (Diluted)	58,691,136	57,667,543	44,569,334	38,356,810	37,668,947	37,348,514	35,898,266	32,065,781	·	·	·
EBITDA	$-132M	$-83M	$122M	$-51M	$-74M	$27M	$-52M	$-91M	$-72M	$-41M	$-20M

Stato Patrimoniale 23

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	$65M	$71M	$69M	$99M	$117M	$104M	$86M	$47M	$32M	$37M	$31M
Short-term Investments	$131M	$195M	$162M	$20M	$15M	$77M	$195M	$109M	$138M	·	·
Receivables	$2M	$2M	$80M	·	·	·	·	·	·	·	·
Prepaid Expense	$4M	$8M	$5M	$5M	$3M	$9M	$5M	$7M	$3M	$4M	$2M
Other Current Assets	$2M	$3M	$3M	$4M	$2M	$2M	$1M	$1M	$766.0K	$2M	$424.0K
Current Assets	$203M	$277M	$320M	$124M	$137M	$198M	$305M	$162M	$172M	$179M	$196M
PP&E (Net)	$13M	$14M	$16M	$18M	$22M	$25M	$18M	$13M	$10M	$8M	$3M
PP&E (Gross)	$32M	$30M	$32M	$35M	$38M	$37M	$26M	$18M	$13M	$9M	$4M
Accum. Depreciation	$19M	$16M	$15M	$17M	$16M	$12M	$8M	$5M	$3M	$1M	$784.0K
Total Assets	$252M	$393M	$351M	$159M	$194M	$262M	$355M	$177M	$184M	$190M	$229M
Accounts Payable	$5M	$4M	$2M	$3M	$574.0K	$634.0K	$4M	$1M	$1M	$550.0K	$612.0K
Accrued Liabilities	$12M	$14M	$17M	$8M	$11M	$14M	$22M	$10M	$11M	$6M	$3M
Current Liabilities	$27M	$50M	$65M	$73M	$51M	$27M	$76M	$32M	$16M	$14M	$24M
Capital Leases	$29M	$36M	$17M	$20M	$39M	$43M	$31M	·	·	·	·
Other Non-current Liabilities	·	$37M	$18M	$21M	$40M	$44M	$32M	$7M	$1M	$25.0K	$44.0K
Total Liabilities	$56M	$93M	$115M	$100M	$99M	$107M	$255M	$131M	$50M	$54M	$60M
Common Stock	$59.0K	$55.0K	$44.0K	$38.0K	$38.0K	$37.0K	$37.0K	$32.0K	$32.0K	$26.0K	$25.0K
Paid-in Capital	$642M	$626M	$498M	$453M	$442M	$430M	$412M	$316M	$295M	$226M	$219M
Retained Earnings	$-446M	$-326M	$-261M	$-394M	$-347M	$-276M	$-313M	$-269M	$-161M	$-90M	$-50M
AOCI	$32.0K	$-407.0K	$-48.0K	$-219.0K	$-138.0K	$-134.0K	$-104.0K	$-133.0K	$-287.0K	$-52.0K	$-251.0K
Stockholders' Equity	$196M	$300M	$236M	$59M	$95M	$154M	$100M	$46M	$134M	$136M	$169M
Liabilities + Equity	$252M	$393M	$351M	$159M	$194M	$262M	$355M	$177M	$184M	$190M	$229M
Shares Outstanding	59,047,860	54,731,316	44,038,333	38,613,891	37,918,395	37,368,027	36,865,116	32,364,895	31,572,044	25,597,912	24,930,979

Flusso di cassa 11

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Stock-based Comp	$15M	$15M	$11M	$9M	$11M	$15M	$16M	$16M	$9M	$6M	$4M
Deferred Tax	·	·	·	·	·	·	·	·	·	$-128.0K	·
Operating Cash Flow	$-132M	$-15M	$78M	$-13M	$-54M	$-97M	$49M	$-16M	$-61M	$-42M	$41M
CapEx	$3M	$4M	$3M	$2M	$2M	$12M	$8M	$4M	$4M	$5M	$1M
Investing Cash Flow	$125M	$-95M	$-142M	$-7M	$66M	$113M	$-90M	$26M	$-4M	$48M	$-195M
Stock Issued	·	$93M	·	·	·	·	·	·	$58M	·	·
Net Stock Activity	·	$93M	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$816.0K	$114M	$34M	$1M	$612.0K	$3M	$81M	$5M	$60M	$514.0K	$178M
Net Change in Cash	$-6M	$4M	$-30M	$-19M	$13M	$19M	$39M	$15M	$-5M	$6M	$24M
Taxes Paid	$714.0K	$1M	$16.0K	·	·	·	·	·	·	·	·
Free Cash Flow	$-135M	$-19M	$75M	$-15M	$-55M	$-109M	$41M	$-20M	$-65M	$-48M	$40M

Redditività 7

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Operating Margin	-326.6%	-104.1%	48.8%	-124.3%	-196.8%	16.0%	-49.5%	-1195.6%	-709.1%	-290.4%	-116.9%
Net Margin	-296.5%	-81.2%	52.9%	-113.5%	-190.3%	21.5%	-41.8%	-1158.8%	-697.6%	-282.6%	-171.2%
Pretax Margin	-296.2%	-80.4%	53.5%	-113.4%	·	21.5%	-41.8%	-1161.1%	-697.6%	-282.3%	·
EBITDA Margin	-326.6%	-104.1%	48.8%	-124.3%	-196.8%	16.0%	-49.5%	-1195.6%	-709.1%	-290.4%	-116.9%
ROA	-37.1%	-17.5%	51.8%	-26.3%	-31.3%	11.9%	-16.4%	-48.8%	-37.8%	-19.2%	-24.6%
ROE	-54.4%	-20.6%	64.1%	-66.8%	-78.0%	22.9%	-42.0%	-157.6%	-52.4%	-26.4%	-40.0%
ROIC	-67.3%	-28.1%	51.1%	-86.2%	·	·	·	-195.7%	·	-30.4%	·

Liquidità e Solvibilità 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Current Ratio		7.6	5.6	5.0	1.7	2.7	7.4	4.0	5.1	10.8	13.0	8.2
Quick Ratio		7.5	5.4	4.8	1.6	2.6	6.8	3.7	4.9	2.0	2.7	1.3

Efficienza 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Asset Turnover		0.1	0.2	1.0	0.2	0.2	0.6	0.4	0.0	0.1	0.1	0.1
Receivables Turnover		24.7	2.0	6.2	·	·	·	·	·	·	·	·

Per Azione 7

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Book Value / Share	$3.32	$5.48	$5.37	$1.53	$2.51	$4.13	$2.70	$1.44	$4.25	$5.31	$6.78
Revenue / Share	$0.69	$1.39	$5.61	$1.07	$0.99	$4.58	·	·	·	·	·
Cash Flow / Share	$-2.26	$-0.27	$1.75	$-0.33	$-1.42	$-2.59	·	·	·	·	·
Cash / Share	$1.11	$1.30	$1.56	$2.56	$3.10	$2.79	$2.33	$1.45	$1.00	$1.43	$1.26
Dividend / Share	·	·	·	·	$0.00	$0.00	$0.00	$0.00	·	$0.00	$0.00
Dividend Paid / Share	·	·	·	·	$0.00	$0.00	$0.00	$0.00	·	$0.00	$0.00
EPS (TTM)	$-2.04	$-1.13	$2.97	$-1.21	$-1.89	$0.98	$-1.21	$-2.75	·	·	·

Tassi di Crescita 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue YoY	-49.5%	-68.0%	511.2%	9.3%	-78.1%	·	·	·	·	·	·
Revenue CAGR 3Y	-0.44%	28.8%	13.5%	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	-25.1%	·	·	·	·	·	·	·	·	·	·
EPS CAGR 3Y	·	·	44.7%	·	·	·	·	·	·	·	·
Net Income CAGR 3Y	·	·	53.3%	·	·	·	·	·	·	·	·

Valutazione (TTM) 10

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue TTM	$40M	$80M	$250M	$41M	$37M	$171M	$104M	$8M	$10M	$14M	$17M
Net Income TTM	$-120M	$-65M	$132M	$-46M	$-71M	$37M	$-44M	$-88M	$-71M	$-40M	$-30M
Market Cap	$232M	$310M	$372M	$236M	$103M	$267M	$514M	$304M	$524M	$326M	$546M
P/E	-1.9	-5.0	2.8	-5.0	-1.4	7.3	-11.5	-3.4	·	·	·
P/S	5.7	3.9	1.5	5.8	2.7	1.6	4.9	39.9	51.7	22.9	31.5
P/B	1.2	1.0	1.6	4.0	1.1	1.7	5.2	6.6	3.9	2.4	3.2
P / Tangible Book	1.2	1.0	1.6	4.0	1.1	1.7	·	·	·	·	·
P / Cash Flow	-1.8	-20.3	4.8	-18.8	-1.9	-2.8	10.6	-19.1	-8.5	-7.7	13.2
P / FCF	-1.7	-16.5	5.0	-15.7	-1.9	-2.5	12.6	-15.1	-8.0	-6.9	13.6
Earnings Yield	-51.9%	-19.9%	35.2%	-19.8%	-69.7%	13.7%	-8.7%	-29.3%	·	·	·

Conto Economico 14

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Revenue	$3M	$3M	$15M	$13M	$5M	$6M	$6M	$25M	$30M	$20M	$90M	$5M	$5M	$150M	$41M	$712.0K
R&D Expense	$22M	$25M	$36M	$36M	$31M	$32M	$36M	$30M	$34M	$27M	$26M	$26M	$22M	$19M	$19M	$13M
SG&A Expense	$8M	$8M	$9M	$8M	$10M	$10M	$9M	$8M	$10M	$9M	$10M	$8M	$8M	$9M	$7M	$8M
Operating Expenses	$30M	$33M	$45M	$44M	$42M	$41M	$45M	$38M	$45M	$36M	$36M	$34M	$30M	$28M	$27M	$20M
Operating Income	$-26M	$-30M	$-30M	$-31M	$-37M	$-35M	$-38M	$-14M	$-15M	$-16M	$54M	$-30M	$-25M	$123M	$14M	$-19M
Other Non-op	$411.0K	$435.0K	$404.0K	$400.0K	$427.0K	$418.0K	$-4M	$200.0K	$20.0K	$5M	$0	$0	$3.0K	$2M	$3M	$61.0K
Pretax Income	$-24M	$-28M	$-27M	$-28M	$-33M	$-31M	$-34M	$-9M	$-10M	$-11M	$57M	$-26M	$-22M	$125M	$18M	$-19M
Income Tax	$20.0K	$14.0K	$9.0K	$83.0K	$15.0K	$37.0K	$584.0K	$43.0K	$24.0K	$14.0K	$822.0K	$-177.0K	$59.0K	$704.0K	·	·
Net Income	$-24M	$-28M	$-27M	$-28M	$-33M	$-31M	$-34M	$-9M	$-10M	$-11M	$56M	$-26M	$-22M	$124M	$18M	$-19M
EPS (Basic)	$-0.40	$-0.47	$-0.47	$-0.47	$-0.57	$-0.53	$-0.59	$-0.16	$-0.18	$-0.20	$1.13	$-0.59	$-0.51	$3.05	$0.46	$-0.50
EPS (Diluted)	$-0.40	$-0.47	$-0.47	$-0.47	$-0.57	$-0.53	$-0.59	$-0.16	$-0.18	$-0.20	$1.13	$-0.59	$-0.51	$2.94	$0.45	$-0.50
Shares (Basic)	60,547,863	59,496,329	·	58,803,015	58,666,460	58,349,769	·	57,851,110	57,721,934	57,117,046	·	43,864,838	43,520,137	40,632,087	38,507,542	38,298,426
Shares (Diluted)	60,547,863	59,496,329	·	58,803,015	58,666,460	58,349,769	·	57,851,110	57,721,934	57,117,046	·	43,864,838	43,520,137	42,161,326	39,570,394	38,298,426
EBITDA	$-26M	$-30M	·	$-31M	$-37M	$-35M	·	$-14M	$-15M	$-16M	·	$-30M	$-25M	$123M	$14M	$-19M

Stato Patrimoniale 24

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Cash & Equivalents	$36M	$43M	$65M	$45M	$44M	$75M	$71M	$113M	$76M	$143M	·	$65M	$244M	$268M	$97M	$78M
Short-term Investments	$81M	$98M	$131M	$164M	$172M	$161M	$195M	$233M	$295M	$256M	·	$188M	$28M	$5M	$35M	$70M
Receivables	$3M	$1M	$2M	$3M	$2M	$2M	$2M	$16M	$2M	$837.0K	·	·	·	$25M	$10M	·
Prepaid Expense	$6M	$4M	$4M	$7M	$10M	$7M	$8M	$8M	$7M	$6M	·	$6M	$6M	$4M	$5M	$3M
Other Current Assets	·	·	$2M	·	·	·	$3M	·	·	·	·	·	·	·	·	·
Current Assets	$125M	$147M	$203M	$220M	$228M	$245M	$277M	$373M	$382M	$409M	·	$262M	$282M	$303M	$147M	$152M
PP&E (Net)	$11M	$12M	$13M	$13M	$14M	$14M	$14M	$15M	$16M	$17M	·	$17M	$17M	$17M	$18M	$19M
PP&E (Gross)	·	·	$32M	·	·	·	$30M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$19M	·	·	·	$16M	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$214.0K	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Total Assets	$198M	$219M	$252M	$288M	$322M	$353M	$393M	$426M	$436M	$470M	·	$295M	$316M	$336M	$182M	$189M
Accounts Payable	$2M	$3M	$5M	$2M	$2M	$3M	$4M	$3M	$3M	$8M	·	$3M	$2M	$4M	$1M	$1M
Accrued Liabilities	$8M	$7M	$12M	$15M	$12M	$9M	$14M	$11M	$10M	$8M	·	$11M	$9M	$8M	$13M	$7M
Current Liabilities	$17M	$17M	$27M	$35M	$42M	$40M	$50M	$44M	$40M	$73M	·	$62M	$45M	$20M	$73M	$98M
Capital Leases	$26M	$27M	$29M	$31M	$33M	$35M	$36M	$38M	$40M	$42M	·	$18M	$19M	$20M	$21M	$22M
Other Non-current Liabilities	·	·	·	·	·	·	·	$39M	$41M	$43M	·	$19M	$20M	$21M	$22M	$23M
Total Liabilities	$43M	$46M	$56M	$68M	$78M	$81M	$93M	$96M	$101M	$129M	·	$118M	$117M	$119M	$103M	$129M
Common Stock	$61.0K	$60.0K	$59.0K	$56.0K	$56.0K	$55.0K	$55.0K	$55.0K	$54.0K	$54.0K	·	$44.0K	$44.0K	$43.0K	$38.0K	$38.0K
Paid-in Capital	$653M	$648M	$642M	$638M	$635M	$630M	$626M	$622M	$619M	$614M	·	$494M	$491M	$487M	$450M	$448M
Retained Earnings	$-498M	$-474M	$-446M	$-418M	$-391M	$-357M	$-326M	$-292M	$-283M	$-273M	·	$-318M	$-292M	$-269M	$-370M	$-388M
AOCI	$-421.0K	$-263.0K	$32.0K	$7.0K	$-221.0K	$-199.0K	$-407.0K	$-33.0K	$-522.0K	$-506.0K	·	$-248.0K	$-133.0K	$-132.0K	$-337.0K	$-364.0K
Stockholders' Equity	$154M	$174M	$196M	$220M	$244M	$273M	$300M	$330M	$335M	$341M	$236M	$176M	$199M	$217M	$80M	$60M
Liabilities + Equity	$198M	$219M	$252M	$288M	$322M	$353M	$393M	$426M	$436M	$470M	·	$295M	$316M	$336M	$182M	$189M
Shares Outstanding	61,273,390	60,310,526	59,047,860	55,482,262	55,434,956	55,209,485	54,731,316	54,542,048	54,472,113	54,318,133	·	43,909,161	43,759,409	43,435,889	38,520,336	38,439,251

Flusso di cassa 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Stock-based Comp	$2M	$2M	$4M	$3M	$4M	$4M	$4M	$3M	$4M	$4M	$3M	$3M	$3M	$3M	$2M	$2M
Operating Cash Flow	$-26M	$-33M	$-30M	$-31M	$-33M	$-38M	$-15M	$-28M	$-32M	$59M	$-24M	$-21M	$-835.0K	$124M	$-16M	$-18M
CapEx	$0	$14.0K	$626.0K	$207.0K	$1M	$658.0K	$155.0K	$258.0K	$967.0K	$2M	$755.0K	$782.0K	$1M	$509.0K	$278.0K	$1M
Investing Cash Flow	$15M	$8M	$47M	$35M	$2M	$41M	$-27M	$64M	$-36M	$-96M	$27M	$-158M	$-25M	$14M	$35M	$-36M
Stock Issued	$3M	$3M	·	·	·	·	$0	$0	$0	$93M	·	·	·	·	·	·
Net Stock Activity	·	$3M	·	·	·	·	·	·	·	$93M	·	·	·	·	·	·
Financing Cash Flow	$3M	$3M	$136.0K	$85.0K	$513.0K	$82.0K	$574.0K	$14.0K	$571.0K	$113M	$460.0K	$331.0K	$2M	$31M	$15.0K	$807.0K
Net Change in Cash	$-8M	$-22M	$17M	$4M	$-31M	$3M	$-41M	$36M	$-67M	$76M	$4M	$-179M	$-24M	$169M	$19M	$-54M
Free Cash Flow	·	$-33M	·	·	·	$-39M	·	·	·	$57M	·	·	·	$123M	·	·

Redditività 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Operating Margin	-833.9%	-1167.4%	·	-228.9%	-704.3%	-536.0%	·	-56.0%	-50.8%	-82.9%	·	-639.5%	-523.9%	81.7%	35.1%	-2720.1%
Net Margin	-773.2%	-1077.4%	·	-208.7%	-642.0%	-479.2%	·	-36.7%	-34.3%	-58.1%	·	-561.4%	-457.6%	82.4%	42.9%	-2680.8%
Pretax Margin	-772.6%	-1076.9%	·	-208.1%	-641.7%	-478.7%	·	-36.5%	-34.2%	-58.0%	·	-565.2%	-456.4%	82.9%	·	·
EBITDA Margin	-833.9%	-1167.4%	·	-228.9%	-704.3%	-536.0%	·	-56.0%	-50.8%	-82.9%	·	-639.5%	-523.9%	81.7%	35.1%	-2720.1%
ROA	-9.4%	-9.8%	·	-7.8%	-8.8%	-7.5%	·	-2.5%	-2.7%	-2.8%	·	-10.9%	-8.8%	44.3%	9.6%	-9.6%
ROE	-12.3%	-12.5%	·	-10.1%	-11.5%	-10.1%	·	-3.6%	-3.8%	-4.1%	·	-20.2%	-17.1%	84.7%	21.1%	-22.4%
ROIC	-17.1%	-17.4%	·	-14.0%	-15.0%	-12.7%	·	-4.2%	-4.5%	-4.8%	·	-16.6%	-12.8%	56.3%	·	·

Liquidità e Solvibilità 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Current Ratio		7.5	8.4	·	6.2	5.4	6.1	·	8.4	9.5	5.6	·	4.2	6.2	15.2	2.0	1.5
Quick Ratio		7.1	8.2	·	6.0	5.2	5.9	·	8.2	9.3	5.5	·	4.1	6.0	15.0	1.9	1.5

Efficienza 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	0.1	0.1	0.0	·	0.0	0.0	0.5	0.2	0.0
Receivables Turnover		1.4	1.7	·	1.4	3.1	5.3	·	1.9	34.8	1.5	·	·	·	12.0	8.2	·

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Book Value / Share	$2.52	$2.88	·	$3.96	$4.40	$4.94	·	$6.06	$6.16	$6.28	·	$4.01	$4.55	$5.00	$2.07	$1.56
Revenue / Share	$0.05	$0.04	·	$0.23	$0.09	$0.11	·	$0.43	$0.51	$0.34	·	$0.11	$0.11	$3.57	$1.04	$0.02
Cash Flow / Share	·	$-0.56	·	·	·	$-0.65	·	·	·	$1.03	·	·	·	$2.93	·	·
Cash / Share	$0.58	$0.72	·	$0.81	$0.79	$1.35	·	$2.06	$1.40	$2.63	·	$1.49	$5.58	$6.18	$2.51	$2.04
EPS (TTM)	$-1.81	$-1.98	·	$-2.16	$-1.85	$-1.46	·	$0.59	$0.16	$-0.17	·	$1.24	$2.28	$2.29	$-0.45	$-1.57

Valutazione (TTM) 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Revenue TTM	$34M	$36M	·	$31M	$43M	$67M	·	$164M	$144M	$119M	·	$158M	$195M	$191M	$71M	$31M
Net Income TTM	$-108M	$-117M	·	$-127M	$-108M	$-85M	·	$26M	$9M	$-3M	·	$52M	$96M	$99M	$-17M	$-60M
Market Cap	$214M	$233M	·	$259M	$172M	$187M	·	$319M	$431M	$506M	·	$340M	$501M	$335M	$228M	$227M
P/E	-1.9	-1.9	·	-2.2	-1.7	-2.3	·	9.9	49.4	-54.8	·	6.2	5.0	3.4	-13.2	-3.8
P/S	6.2	6.4	·	8.3	4.0	2.8	·	1.9	3.0	4.2	·	2.1	2.6	1.8	3.2	7.3
P/B	1.4	1.3	·	1.2	0.7	0.7	·	1.0	1.3	1.5	·	1.9	2.5	1.5	2.9	3.8
P / Tangible Book	1.4	1.3	·	1.2	0.7	0.7	·	1.0	1.3	1.5	·	1.9	2.5	1.5	2.9	3.8
P / Cash Flow	·	-7.0	·	·	·	-4.9	·	·	·	8.6	·	·	·	2.7	·	·
Earnings Yield	-51.7%	-51.3%	·	-46.2%	-59.5%	-43.2%	·	10.1%	2.0%	-1.8%	·	16.0%	19.9%	29.7%	-7.6%	-26.6%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$40M	$80M	$250M	$41M	$37M
Margine Operativo %	-326.6%	-104.1%	48.8%	-124.3%	-196.8%
Utile netto	$-120M	$-65M	$132M	$-46M	$-71M
EPS Diluito	$-2.04	$-1.13	$2.97	$-1.21	$-1.89

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	7.6	5.6	5.0	1.7	2.7
Quick Ratio	7.5	5.4	4.8	1.6	2.6

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-135M	$-19M	$75M	$-15M	$-55M

Proprietari istituzionali (13F) 149 filer · $135.5M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 149

Valore detenuto $135.5M

Nuove posizioni 22

Posizioni chiuse 16

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
22 (-10 vs trimestre precedente)	16 (0 vs trimestre precedente)	58 (+12 vs trimestre precedente)	35 (0 vs trimestre precedente)	+1.9M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
BlackRock, Inc.	$18.102.222	5.172.063	13,36%	Azioni
MILLENNIUM MANAGEMENT LLC	$15.550.328	4.442.951	11,48%	Azioni
VANGUARD GROUP INC	$12.837.282	3.266.484	9,47%	Azioni
ARMISTICE CAPITAL, LLC	$12.026.000	3.436.000	8,87%	Azioni
Vestal Point Capital, LP	$9.187.500	2.625.000	6,78%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$8.209.859	2.345.674	6,06%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$4.658.199	1.330.492	3,44%	Azioni
Opaleye Management Inc.	$4.147.500	1.185.000	3,06%	Azioni
STATE STREET CORP	$3.767.477	1.076.422	2,78%	Azioni
TWO SIGMA INVESTMENTS, LP	$3.319.810	948.517	2,45%	Azioni
DIMENSIONAL FUND ADVISORS LP	$2.933.984	838.184	2,17%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$2.835.319	810.091	2,09%	Azioni
CITADEL ADVISORS LLC	$2.744.235	784.067	2,03%	Azioni
MORGAN STANLEY	$2.440.672	697.334	1,80%	Azioni
Erste Asset Management GmbH	$2.287.262	638.900	1,69%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$1.733.326	495.236	1,28%	Azioni
SPHERA FUNDS MANAGEMENT LTD.	$1.496.439	427.554	1,10%	Azioni
DIADEMA PARTNERS LP	$1.447.747	413.642	1,07%	Azioni
NORTHERN TRUST CORP	$1.441.311	411.803	1,06%	Azioni
AQR CAPITAL MANAGEMENT LLC	$1.246.383	356.109	0,92%	Azioni
GOLDMAN SACHS GROUP INC	$1.184.670	338.477	0,87%	Azioni
VANGUARD FIDUCIARY TRUST CO	$1.180.638	337.325	0,87%	Azioni
Fiduciary Trust Co	$1.170.390	334.397	0,86%	Azioni
JPMORGAN CHASE & CO	$988.836	276.211	0,73%	Azioni
Point72 Asset Management, L.P.	$826.291	236.083	0,61%	Azioni
PANAGORA ASSET MANAGEMENT INC	$808.770	231.077	0,60%	Azioni
Seven Fleet Capital Management LP	$771.860	230.406	0,57%	Azioni
Invesco Ltd.	$743.222	212.349	0,55%	Azioni
Qube Research & Technologies Ltd	$679.172	194.049	0,50%	Azioni
FMR LLC	$615.537	175.868	0,45%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$530.079	151.451	0,39%	Azioni
DIADEMA PARTNERS LP	$525.000	150.000	0,39%	Opzione Call
AMERICAN CENTURY COMPANIES INC	$514.059	146.874	0,38%	Azioni
Bank of New York Mellon Corp	$512.946	146.556	0,38%	Azioni
D. E. Shaw & Co., Inc.	$503.973	143.992	0,37%	Azioni
Altshuler Shaham Ltd	$497.700	142.200	0,37%	Azioni
MARSHALL WACE, LLP	$487.980	139.422	0,36%	Azioni
WELLS FARGO & COMPANY/MN	$437.647	125.042	0,32%	Azioni
Susquehanna Portfolio Strategies, LLC	$431.193	123.198	0,32%	Azioni
Privium Fund Management B.V.	$420.000	120.000	0,31%	Azioni
Nuveen, LLC	$409.851	117.100	0,30%	Azioni
CAPTRUST FINANCIAL ADVISORS	$391.954	111.987	0,29%	Azioni
CITADEL ADVISORS LLC	$372.400	106.400	0,27%	Opzione Call
Persistent Asset Partners Ltd	$365.901	104.543	0,27%	Azioni
BARCLAYS PLC	$357.716	102.204	0,26%	Azioni
Verition Fund Management LLC	$350.000	100.000	0,26%	Opzione Call
Patriot Financial Group Insurance Agency, LLC	$336.175	96.050	0,25%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$318.147	90.899	0,23%	Azioni
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$306.107	87.459	0,23%	Azioni
ALLIANCEBERNSTEIN L.P.	$266.533	69.050	0,20%	Azioni

Mostra tutti i 149 proprietari istituzionali →

Insider aziendali 35 insider · 17 dirigenti · 15 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Alfred Sandrock	President and CEO	02 Aprile 2026 S	472.549	3	$-144.441
Andre Turenne	President & CEO	19 Marzo 2021 A	322.375	0	$0
Nathan D. Jorgensen	Chief Financial Officer	24 Febbraio 2026 S	151.416	2	$-54.241
Peter P. Pfreundschuh	Chief Financial Officer	21 Febbraio 2024 S	175.669	0	$0
Jane Henderson	Sr. V.P. & CFO, Corp. Dev.	23 Marzo 2018 M	0	0	$0
Jeff Goater	Chief Financial Officer	01 Febbraio 2016 A	·	0	$0
Robin Swartz	COO & CBO	24 Febbraio 2026 S	199.738	3	$-55.292
Matthew P. Ottmer	Chief Operating Officer	21 Gennaio 2020 S	26.276	0	$0
Gregory L. Shiferman	SVP and General Counsel	01 Aprile 2026 A	50.000	0	$0
Todd Alfred Carter	Chief Scientific Officer	24 Febbraio 2026 S	145.718	3	$-40.620
Toby Ferguson	Chief Medical Officer	06 Febbraio 2026 A	183.914	0	$0
Sandell Jacquelyn Fahey	Chief Legal Officer	21 Febbraio 2025 A	123.143	0	$0
Robert W. Hesslein	Senior VP & General Counsel	20 Marzo 2023 S	102.200	0	$0
Julie Burek	VP, Finance	21 Marzo 2022 S	52.458	0	$0
Omar Khwaja	Chief Medical Officer and Head of Research & Development.	21 Maggio 2021 S	120.509	0	$0
Dinah Sah Ph.D.	Chief Scientific Officer	11 Gennaio 2019 A	163.688	0	$0
Bernard Ravina	Chief Medical Officer	10 Aprile 2018 S	0	0	$0
Jude Onyia	Direttore	09 Giugno 2026 A	·	0	$0
Nancy Vitale	Direttore	09 Giugno 2026 A	·	0	$0
Grace Colon	Direttore	09 Giugno 2026 A	·	0	$0
Steven Hyman	Direttore	09 Giugno 2026 A	·	0	$0
Catherine J Mackey	Direttore	09 Giugno 2026 A	·	0	$0
Michael J Higgins	Direttore	09 Giugno 2026 A	31.314	0	$0
Glenn Pierce	Direttore	09 Giugno 2026 A	16.788	0	$0
James A Geraghty	Direttore	09 Giugno 2026 A	76.588	0	$0
George A Scangos	Direttore	09 Giugno 2026 A	·	0	$0
Steven M Paul	Direttore	03 Giugno 2021 A	872.351	0	$0
Mark J Levin	Direttore	03 Giugno 2021 A	6.391.176	0	$0
Wendy L Dixon	Direttore	04 Giugno 2020 A	·	0	$0
Perry A Karsen	Direttore	13 Giugno 2019 A	·	0	$0
NEUROCRINE BIOSCIENCES INC	Proprietario del 10%	23 Febbraio 2023 P	8.575.316	0	$0
EcoR1 Capital, LLC	Proprietario del 10%	11 Gennaio 2023 S	3.851.507	0	$0
Hadley Harbor Master Investors (Cayman) L.P.	Proprietario del 10%	16 Novembre 2015 C	470.588	0	$0
Allison Dorval	·	19 Marzo 2021 A	109.894	0	$0
Sanofi	·	10 Novembre 2015 C	2.477.941	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 22 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
QQQS · Invesco Exchange-Traded Fund Trust …	0,41%	34.783 SH	02 Ottobre 2026	Giornaliero
IBRN · iShares Trust	0,18%	4.106 SH	11 Settembre 2026	Giornaliero
OMFS · Invesco Exchange-Traded Self-Indexe…	0,07%	70.113 SH	02 Ottobre 2026	Giornaliero
IWC · iShares Trust	0,04%	183.069 SH	11 Settembre 2026	Giornaliero
IBB · iShares Trust	0,01%	371.337 SH	11 Settembre 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,01%	4.238 SH	02 Ottobre 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	301.636 SH	19 Agosto 2026	Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS	0,01%	47.877 SH	19 Agosto 2026	Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust	0,01%	82.492 SH	02 Ottobre 2026	Giornaliero
IWM · iShares Trust	0,01%	1.350.887 SH	11 Settembre 2026	Giornaliero
RSSL · Global X Funds	0,01%	25.102 NS	31 Luglio 2026	N-PORT
DFAS · Dimensional ETF Trust	0,00%	84.113 NS	31 Luglio 2026	N-PORT
DXUV · Dimensional ETF Trust	0,00%	2.700 NS	31 Luglio 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	6.400 NS	31 Luglio 2026	N-PORT
DFSV · Dimensional ETF Trust	0,00%	9.664 NS	31 Luglio 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	39.859 NS	31 Luglio 2026	N-PORT
IWV · iShares Trust	0,00%	9.213 SH	03 Settembre 2026	Giornaliero
DFAU · Dimensional ETF Trust	0,00%	5.408 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	613.128 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	1.671.885 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	3.515 SH	19 Agosto 2026	Giornaliero
IWN · iShares Trust	·	487.012 SH	11 Settembre 2026	Giornaliero

VYGR Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 17 analisti COMPRA

Target mediano $12.00 +389,8%

8 47,1% Acquisto forte

8 47,1% Compra

1 5,9% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

9 analisti · 2026-10-01

Target medio $14.89 +507,7%

← Sotto tutti i target Prezzo attuale $2.45

Basso$8.00 Media$14.89 Alto$25.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
VYGR	$232M	-1.9	-49.5%	-296.5%	-54.4%	·
DTIL	$100M	-1.2	-50.1%	-133.4%	-72.4%	·
ORGO	$658M	34.5	17.0%	6.6%	13.9%	·
AVXL	·	-16.5	-36.1%	-991.4%	·	·
ALXO	$61M	-0.6	·	·	-225.0%	·
TARA	$286M	-4.0	·	·	-33.7%	·
PEPG	$448M	-3.1	·	·	-82.0%	·
NERV	$174M	-0.1	·	·	339.5%	·
NBP	$1.06B	-19.0	·	·	-21.4%	·
CMPX	$958M	·	·	·	-45.9%	·
TNXP	$200M	-1.1	29.8%	-946.2%	-60.0%	·

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

VYGR Voyager Therapeutics, Inc. - Common Stock

VYGR Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

VYGR Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Informazioni su Voyager Therapeutics, Inc. - Common Stock Panoramica della società da Wikipedia

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Proprietari istituzionali (13F) 149 filer · $135.5M totale · Aggiornato al 30 Giugno 2026

Insider aziendali 35 insider · 17 dirigenti · 15 direttori

Proprietà ETF Posseduti da 22 ETF

VYGR Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi